TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer

Supplementary Table 1. Clinicopathological characteristics 
of the patients with prostate cancer.

Supplementary figure 1. TUBB3 is overexpressed in docetaxel (DTX) resistant cell lines and cabazitaxel (CBZ) resistant cell lines.
 (A) The results of qRT-PCR for the expression of TUBB3 in parental and DTX resistant cell lines in C4-2 and DU145 cells. The results are expressed as the mean ± S.D. of triplicate measurements. (B) The results of qRT-PCR for the expression of TUBB3 in parental and CBZ resistant cell lines in LNCaP and 22Rv-1 cells. The results are expressed as the mean ± S.D. of triplicate measurements.